| Filed 2024-11-28 10:32 Tx date 2024-11-27 | $ONC
Oncolytics Biotech Inc. | Coffey, Matthew 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 57 - Exercise of rights |
+11,260 vol | 107,593 | |
| Filed 2024-11-28 10:30 Tx date 2024-11-27 | $ONC
Oncolytics Biotech Inc. | Coffey, Matthew 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Rights Restricted Share Units 57 - Exercise of rights |
-26,900 vol | 147,600 | |
| Filed 2024-11-28 10:29 Tx date 2024-11-27 | $ONC
Oncolytics Biotech Inc. | Coffey, Matthew 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Options 52 - Expiration of options |
-200,263 vol | 1,655,368 | |
| Filed 2024-11-28 10:25 Tx date 2024-11-27 | $ONC
Oncolytics Biotech Inc. | Levin, Amy 5 - Senior Officer of Issuer Direct Ownership | Common Shares 57 - Exercise of rights |
+1,229 vol | 1,229 | |
| Filed 2024-11-28 10:24 Tx date 2023-02-24 | $ONC
Oncolytics Biotech Inc. | Levin, Amy 5 - Senior Officer of Issuer Direct Ownership | Common Shares 00 - Opening Balance-Initial SEDI Report | | | |
| Filed 2024-11-28 10:23 Tx date 2024-11-27 | $ONC
Oncolytics Biotech Inc. | Levin, Amy 5 - Senior Officer of Issuer Direct Ownership | Rights Restricted Share Units 57 - Exercise of rights |
-1,966 vol | 19,134 | |
| Filed 2024-11-28 10:18 Tx date 2024-11-27 | $ONC
Oncolytics Biotech Inc. | Heineman, Thomas 5 - Senior Officer of Issuer Direct Ownership | Common Shares 57 - Exercise of rights |
+7,966 vol | 18,966 | |
| Filed 2024-11-28 10:17 Tx date 2024-11-27 | $ONC
Oncolytics Biotech Inc. | Heineman, Thomas 5 - Senior Officer of Issuer Direct Ownership | Rights Restricted Share Units 57 - Exercise of rights |
-7,966 vol | 78,034 | |
| Filed 2024-11-28 10:13 Tx date 2024-11-27 | $ONC
Oncolytics Biotech Inc. | Hagerman, Allison 5 - Senior Officer of Issuer Direct Ownership | Common Shares 57 - Exercise of rights | $3,865,156
+1,966 vol
$1,966 each | 6,166 | |
| Filed 2024-11-28 10:11 Tx date 2024-11-27 | $ONC
Oncolytics Biotech Inc. | Hagerman, Allison 5 - Senior Officer of Issuer Direct Ownership | Rights Restricted Share Units 57 - Exercise of rights |
-1,966 vol | 23,434 | |
| Filed 2024-11-28 10:10 Tx date 2024-11-27 | $ONC
Oncolytics Biotech Inc. | Hagerman, Allison 5 - Senior Officer of Issuer Direct Ownership | Options 52 - Expiration of options |
-112,105 vol | 490,078 | |
| Filed 2024-11-28 10:05 Tx date 2024-11-27 | $ONC
Oncolytics Biotech Inc. | Look, Kirk 5 - Senior Officer of Issuer Direct Ownership | Common Shares 57 - Exercise of rights |
+9,400 vol | 54,428 | |
| Filed 2024-11-28 10:04 Tx date 2024-11-27 | $ONC
Oncolytics Biotech Inc. | Look, Kirk 5 - Senior Officer of Issuer Direct Ownership | Rights Restricted Share Units 57 - Exercise of rights |
-9,400 vol | 80,900 | |
| Filed 2024-11-28 10:01 Tx date 2024-11-27 | $ONC
Oncolytics Biotech Inc. | Look, Kirk 5 - Senior Officer of Issuer Direct Ownership | Options 52 - Expiration of options |
-141,842 vol | 957,120 |